Når annonsen er aktiv kan du tipse en venn Når annonsen er aktiv kan du dele på Facebook Når annonsen er aktiv kan du dele på Twitter
Utløpt

Experienced Scientist in flow cytometry and immune monitoring

Arbeidsgiver
Vaccibody AS
Stillingstittel
Scientist
Frist
Frist utløpt
Varighet
Engasjement

We are looking for a Scientist experienced in flow cytometry and immune monitoring

As a scientist you will take active part in planning, execution and reporting of research activities for advancing the Vaccibody vaccine technology. The tasks will be focused on flow cytometry including assay development and analysis of clinical and pre-clinical samples. In addition, you will take part in in vitro and in vivo pre-clinical experiments to study immunological responses, mode of action and efficacy in internal projects or in collaboration with external partners. Unique opportunity to join our dedicated team and be part of moving the exciting personalized cancer immunotherapy field forward!


Key responsibilities:

  • Expertise in assay development and analysis of clinical and pre-clinical samples by flow cytometry and/or immunohistochemistry (IHC)
  • A strong understanding of T cell immunology and cellular assays (ELISPOT, T cell proliferation, ELISA)
  • Experience with vaccination and treatment of mice (e.g. tumor challenge) 
  • Knowledge of molecular biology for constructing and validation of DNA plasmid vaccines
  • Writing reports and work instructions according to Vaccibody QMS system
  • To initiate, lead and execute laboratory work to advance the Vaccibody vaccine technology  

Experiences/Qualifications/Qualities:

  • Expertise in flow cytometry and/or immunohistochemistry
  • MSc or higher degree in immunology or other relevant scientific discipline  
  • Fluent in English as working language
  • Quality-conscious, structured, proactive and accurate
  • Superior collaboration and communication skills
  • Contribute to positive attitude and excellent working environment
  • Be flexible and ability to prioritize in a dynamic RD team
  • Certified FELASA C preferred
  • Experience from industry preferred

We can offer:

  • Challenging responsibilities in a fun and dynamic work environment
  • A career in one of Norway’s most interesting and rapidly growing biotech companies
  • Opportunity to work with a competent team developing cutting edge technology for improved cancer therapy
  • Development through continuous learning and development of personal skills
  • Collaboration with colleagues who focus on quality and efficiency 

We look forward to receiving your application and CV. Please apply by sending an email to hjodd@vaccibody.com by 15th Nov 2018. 


Om arbeidsgiveren

Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies using the Vaccibody technology to generate best-in-class therapeutics to treat cancers with a high unmet medical need. Vaccibody is a leader in the rapidly developing field of individualized cancer neoantigen vaccines and is and is currently performing a clinical trial making novel personalized cancer neoepitope vaccines where one unique vaccine is designed and manufactured for each patient. In addition, Vaccibody’s first program (VB10.16) a therapeutic DNA vaccine against HPV16 induced pre-malignancies and malignancies This first-in-man study evaluates the safety and immunogenicity of VB10.16 in women with high grade cervical intraepithelial neoplasia (HSIL; CIN 2/3 and has now released very promising 6 months data from the phase 2a. www.vaccibody.com

Nettverk
Facebook LinkedIn Twitter
Sektor
Privat
Sted
0349 Oslo
Bransje
Farmasi og legemiddel
Stillingsfunksjon
Forskning/Stipendiat

Nøkkelord

Forskning, laboratorie, legemiddel, vaksine, immunterapi

Rapportér annonse

FINN-kode
131769923
Sist endret
27. nov 2018 18:56

Spørsmål om stillingen

Kontaktperson
Karoline Schjetne
Stillingstittel
Vice President Scientific Affairs
Mobil
Vis telefonnummer

0349 Oslo

Stort kart Hybridkart Flyfoto

Rapportér annonse

FINN-kode
131769923
Sist endret
27. nov 2018 18:56